Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
When is a paraneoplastic panel indicated when working up patients with neuromuscular conditions?
Related Questions
Should IVIg dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
When and how do you deviate from efgartigimod (Vyvgart) dosing from the drug label recommendation of weekly infusions for four weeks in patients with myasthenia gravis?
When would you refer patients with Parsonage-Turner syndrome for surgical treatment?
How do you approach managing nausea and GI side effects when initiating methotrexate?
When do you start to cross-titrate from steroids to CellCept in patients with Myasthenia Gravis?
What is your approach to light sedation in pediatric EMG?
How do you approach patients with positive LRP4 antibodies without clinical findings of myasthenia gravis?
At what point do you consider weaning steroids or immuno-modulating agents in patients with Myasthenia Gravis?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
What workup do you recommend for patients with symptoms suggestive of saphenous neuropathy?
